Daiichi Life Insurance Co. Ltd. Takes $1.45 Million Position in Xylem Inc. $XYL

Daiichi Life Insurance Co. Ltd. bought a new position in Xylem Inc. (NYSE:XYL) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 12,275 shares of the industrial products company’s stock, valued at approximately $1,451,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Callahan Advisors LLC acquired a new stake in shares of Xylem during the 4th quarter valued at about $1,721,000. Northwestern Mutual Wealth Management Co. raised its position in Xylem by 2,309.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 431,824 shares of the industrial products company’s stock worth $54,314,000 after purchasing an additional 413,904 shares in the last quarter. Abacus Wealth Partners LLC bought a new position in Xylem during the fourth quarter worth about $1,663,000. Norges Bank bought a new position in Xylem during the fourth quarter worth about $361,012,000. Finally, MUFG Securities EMEA plc boosted its holdings in Xylem by 608.1% during the fourth quarter. MUFG Securities EMEA plc now owns 32,990 shares of the industrial products company’s stock valued at $4,493,000 after purchasing an additional 28,331 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Stock Performance

NYSE:XYL opened at $113.62 on Monday. Xylem Inc. has a 1 year low of $105.29 and a 1 year high of $154.27. The firm has a 50 day moving average of $118.04 and a 200-day moving average of $119.67. The company has a current ratio of 1.61, a quick ratio of 1.24 and a debt-to-equity ratio of 0.23. The stock has a market capitalization of $26.53 billion, a P/E ratio of 27.05, a price-to-earnings-growth ratio of 1.57 and a beta of 1.02.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, July 28th. The industrial products company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.34 by $0.12. Xylem had a return on equity of 11.77% and a net margin of 11.15%.The business had revenue of $2.34 billion for the quarter, compared to analyst estimates of $2.34 billion. During the same period in the prior year, the company earned $1.26 EPS. Xylem’s revenue for the quarter was up 1.5% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. As a group, sell-side analysts anticipate that Xylem Inc. will post 5.67 EPS for the current fiscal year.

Xylem Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th will be issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 1.5%. The ex-dividend date is Thursday, August 27th. Xylem’s dividend payout ratio is presently 40.95%.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Oppenheimer dropped their target price on Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a report on Wednesday, April 29th. Royal Bank Of Canada boosted their price target on Xylem from $159.00 to $164.00 and gave the company an “outperform” rating in a research note on Wednesday, July 29th. Barclays upped their price target on Xylem from $154.00 to $159.00 and gave the company an “overweight” rating in a research report on Wednesday, July 29th. Mizuho increased their price objective on Xylem from $124.00 to $130.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 29th. Finally, CLSA raised Xylem to a “hold” rating in a report on Thursday, June 25th. Nine equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $154.23.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.